Registration Document Including Annual Financial Report

Overview

The report describes CARMAT's 2016 transition from feasibility work to the pivotal study and CE-marking preparation, following a €50 million capital increase. The pivotal study began in August but was suspended after the first patient died following battery mishandling; CARMAT said the prosthesis functioned correctly. The company had 56 employees at December 31, 2016 and reported zero revenue while remaining in clinical development.

Document

Report type: Annual Report
Class: Financial
Scope: Full report
Fiscal year: 2016
Period: 1 January 2016 – 31 December 2016
Publication date: 22 March 2017
Language: English
Pages
File size

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services